6-36678211-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001291549.3(CDKN1A):c.97+278G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.232 in 277,810 control chromosomes in the GnomAD database, including 7,018 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 3667 hom., cov: 32)
Exomes 𝑓: 0.25 ( 3351 hom. )
Consequence
CDKN1A
NM_001291549.3 intron
NM_001291549.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.09
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKN1A | NM_001291549.3 | c.97+278G>C | intron_variant | Intron 2 of 3 | NP_001278478.1 | |||
CDKN1A | NM_001374509.1 | c.97+278G>C | intron_variant | Intron 2 of 3 | NP_001361438.1 | |||
CDKN1A | NM_001374510.1 | c.34+1641G>C | intron_variant | Intron 1 of 2 | NP_001361439.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKN1A | ENST00000448526.6 | c.-6+278G>C | intron_variant | Intron 2 of 3 | 3 | ENSP00000409259.3 | ||||
CDKN1A | ENST00000615513.4 | c.-6+1687G>C | intron_variant | Intron 1 of 2 | 2 | ENSP00000482768.1 | ||||
DINOL | ENST00000643333.1 | n.349C>G | non_coding_transcript_exon_variant | Exon 1 of 1 | ||||||
CDKN1A | ENST00000459970.1 | n.189+278G>C | intron_variant | Intron 2 of 2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.218 AC: 33122AN: 151958Hom.: 3658 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
33122
AN:
151958
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.249 AC: 31368AN: 125734Hom.: 3351 Cov.: 0 AF XY: 0.262 AC XY: 18018AN XY: 68818 show subpopulations
GnomAD4 exome
AF:
AC:
31368
AN:
125734
Hom.:
Cov.:
0
AF XY:
AC XY:
18018
AN XY:
68818
African (AFR)
AF:
AC:
894
AN:
2802
American (AMR)
AF:
AC:
1016
AN:
5074
Ashkenazi Jewish (ASJ)
AF:
AC:
926
AN:
3206
East Asian (EAS)
AF:
AC:
673
AN:
4696
South Asian (SAS)
AF:
AC:
8369
AN:
25402
European-Finnish (FIN)
AF:
AC:
1083
AN:
5146
Middle Eastern (MID)
AF:
AC:
129
AN:
486
European-Non Finnish (NFE)
AF:
AC:
16655
AN:
72538
Other (OTH)
AF:
AC:
1623
AN:
6384
Heterozygous variant carriers
0
1058
2116
3174
4232
5290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.218 AC: 33145AN: 152076Hom.: 3667 Cov.: 32 AF XY: 0.217 AC XY: 16111AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
33145
AN:
152076
Hom.:
Cov.:
32
AF XY:
AC XY:
16111
AN XY:
74338
African (AFR)
AF:
AC:
10767
AN:
41462
American (AMR)
AF:
AC:
3034
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
916
AN:
3470
East Asian (EAS)
AF:
AC:
665
AN:
5166
South Asian (SAS)
AF:
AC:
1445
AN:
4822
European-Finnish (FIN)
AF:
AC:
1895
AN:
10576
Middle Eastern (MID)
AF:
AC:
91
AN:
292
European-Non Finnish (NFE)
AF:
AC:
13723
AN:
67980
Other (OTH)
AF:
AC:
548
AN:
2110
Heterozygous variant carriers
0
1328
2656
3983
5311
6639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
348
696
1044
1392
1740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
911
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at